Impact of E1a Modifications on Tumor-Selective Adenoviral Replication and Toxicity

This publication has 44 references indexed in Scilit:

• Preclinical Characterization of the Antiglioma Activity of a Tropism-Enhanced Adenovirus Targeted to the Retinoblastoma Pathway
  JNCI Journal of the National Cancer Institute, 2003
• Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins
  Carcinogenesis: Integrative Cancer Research, 2003
• Acetylation control of the retinoblastoma tumour-suppressor protein
  Nature Cell Biology, 2001
• An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy
  Nature Medicine, 2000
• A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
  Oncogene, 2000
• Targeting the Replication of Adenoviral Gene Therapy Vectors to Lung Cancer Cells: The Importance of the Adenoviral E1b-55kD Gene
  Human Gene Therapy, 1999
• A Viral Mechanism for Inhibition of p300 and PCAF Acetyltransferase Activity
  Cell, 1999
• Regulation of Histone Acetyltransferases p300 and PCAF by the bHLH Protein Twist and Adenoviral Oncoprotein E1A
  Cell, 1999
• p53-dependent cell death/apoptosis is required for a productive adenovirus infection
  Nature Medicine, 1998
• An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells
  Science, 1996